Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide

Search this Article

Author(s)

    • MATSUNAGA Kazuko
    • Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Therapy, Departments of Internal Medicine, Kurume University School of Medicine
    • NAKAO Masanobu
    • Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Therapy, Departments of Internal Medicine, Kurume University School of Medicine
    • INOUE Yoshiko
    • Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Therapy, Departments of Internal Medicine, Kurume University School of Medicine
    • IMAIZUMI Toshihiro
    • Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Therapy, Departments of Internal Medicine, Kurume University School of Medicine
    • NISHIZAKA Shinya
    • Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Therapy, Departments of Internal Medicine, Kurume University School of Medicine
    • ITOH Kyogo
    • Cancer Vaccine Development Division of Kurume University Research Center for Innovative Cancer Therapy, Departments of Internal Medicine, Kurume University School of Medicine

Journal

  • Japanese journal of cancer research : gann

    Japanese journal of cancer research : gann 90(9), 1007-1015, 1999-09-30

References:  37

Codes

  • NII Article ID (NAID)
    10008092645
  • NII NACSIS-CAT ID (NCID)
    AA00690844
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    09105050
  • Data Source
    CJP 
Page Top